Author

Dana Troyke

Observed name: D. Troyke

Institution: Allergopharma GmbH & Co. KG (Germany)

Observed institution: Allergopharma GmbH & Co. KG (Germany)

ORCID: 0009-0005-5816-0300

Observed ORCID: 0009-0005-5816-0300

OpenAlex ID: A5126643744

One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable

2024 · M. Jutel, C. Vogelberg, et al. · Allergy · 6

A One‐Strength Dose Escalation Regimen for Birch Pollen Subcutaneous Immunotherapy Is Safe and Tolerable in Children, Adolescents, and Adults

2026 · Marek Jutel, Ludger Klimek, et al. · Allergy · 1

Safety and tolerability of a One-Strength dose-escalation regimen with house dust mite subcutaneous immunotherapy in routine medical care

2026 · Matthias Kühnemund, Thomas Futschik, et al. · Allergo Journal International

Works count: 3

Citation count: 7

H-index: 1

I10-index: